Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.5 | 1.44 |
NAV | ₹91.02 | ₹107.67 |
Fund Started | 23 Dec 2005 | 08 Apr 2008 |
Fund Size | ₹50502.29 Cr | ₹63938.03 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year | Exit load of 1% if redeemed upto 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 20.92% | 25.67% |
3 Year | 13.89% | 17.95% |
5 Year | 17.31% | 19.76% |
1 Year
3 Year
5 Year
Equity | 96.89% | 92.69% |
Cash | 2.22% | 6.96% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.84% |
ICICI Bank Ltd. | 7.47% |
Infosys Ltd. | 5.04% |
ITC Ltd. | 4.75% |
Larsen & Toubro Ltd. | 4.57% |
Reliance Industries Ltd. | 3.99% |
Tata Consultancy Services Ltd. | 3.86% |
Divi's Laboratories Ltd. | 3.34% |
Kotak Mahindra Bank Ltd. | 3.22% |
State Bank of India | 2.87% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.14% |
ICICI Bank Ltd. | 8.24% |
Larsen & Toubro Ltd. | 6.64% |
Infosys Ltd. | 4.87% |
Reliance Industries Ltd. | 4.41% |
Bharti Airtel Ltd. | 4.37% |
Axis Bank Ltd. | 4.17% |
Maruti Suzuki India Ltd. | 4.11% |
Ultratech Cement Ltd. | 4.01% |
Sun Pharmaceutical Industries Ltd. | 2.80% |
Name | Sohini Andani | Vaibhav Dusad |
Start Date | 16 Sep 2010 | 02 May 2020 |
Name
Start Date
Description | The scheme seeks to provide investors with opportunities for long-term growth in capital through an active management of investments in a diversified basket of large cap equity stocks (as specified by SEBI/AMFI from time to time). | The scheme seeks to generate long term capital appreciation and income distribution to investors from a portfolio that is predominantly invested in equity and equity related securities of large cap companies. |
Launch Date | 23 Dec 2005 | 08 Apr 2008 |
Description
Launch Date